vs
Side-by-side financial comparison of Caledonia Mining Corp Plc (CMCL) and Cytek Biosciences, Inc. (CTKB). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $46.9M, roughly 1.3× Caledonia Mining Corp Plc). Caledonia Mining Corp Plc runs the higher net margin — 7.0% vs -70.9%, a 77.9% gap on every dollar of revenue. On growth, Caledonia Mining Corp Plc posted the faster year-over-year revenue change (13.8% vs 8.1%). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 17.1%).
Hochschild Mining plc is a leading British-based silver and gold mining business operating in North, Central, and South America. It is headquartered in Lima, Peru, with a corporate office in London, is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. The main shareholder is the Peruvian businessman Eduardo Hochschild.
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
CMCL vs CTKB — Head-to-Head
Income Statement — Q3 FY2024 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $46.9M | $62.1M |
| Net Profit | $3.3M | $-44.1M |
| Gross Margin | 41.2% | 52.9% |
| Operating Margin | 18.6% | -9.0% |
| Net Margin | 7.0% | -70.9% |
| Revenue YoY | 13.8% | 8.1% |
| Net Profit YoY | -33.3% | -557.1% |
| EPS (diluted) | $0.13 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $62.1M | ||
| Q3 25 | — | $52.3M | ||
| Q2 25 | — | $45.6M | ||
| Q1 25 | — | $41.5M | ||
| Q4 24 | — | $57.5M | ||
| Q3 24 | $46.9M | $51.5M | ||
| Q2 24 | $50.1M | $46.6M | ||
| Q1 24 | $38.5M | $44.9M |
| Q4 25 | — | $-44.1M | ||
| Q3 25 | — | $-5.5M | ||
| Q2 25 | — | $-5.6M | ||
| Q1 25 | — | $-11.4M | ||
| Q4 24 | — | $9.6M | ||
| Q3 24 | $3.3M | $941.0K | ||
| Q2 24 | $10.2M | $-10.4M | ||
| Q1 24 | $2.1M | $-6.2M |
| Q4 25 | — | 52.9% | ||
| Q3 25 | — | 52.7% | ||
| Q2 25 | — | 52.3% | ||
| Q1 25 | — | 48.6% | ||
| Q4 24 | — | 58.5% | ||
| Q3 24 | 41.2% | 56.3% | ||
| Q2 24 | 45.8% | 54.6% | ||
| Q1 24 | 35.9% | 51.3% |
| Q4 25 | — | -9.0% | ||
| Q3 25 | — | -17.6% | ||
| Q2 25 | — | -23.3% | ||
| Q1 25 | — | -36.1% | ||
| Q4 24 | — | 5.2% | ||
| Q3 24 | 18.6% | -8.2% | ||
| Q2 24 | 32.2% | -18.3% | ||
| Q1 24 | 13.8% | -23.9% |
| Q4 25 | — | -70.9% | ||
| Q3 25 | — | -10.5% | ||
| Q2 25 | — | -12.2% | ||
| Q1 25 | — | -27.5% | ||
| Q4 24 | — | 16.8% | ||
| Q3 24 | 7.0% | 1.8% | ||
| Q2 24 | 20.3% | -22.4% | ||
| Q1 24 | 5.4% | -13.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $0.13 | — | ||
| Q2 24 | $0.42 | — | ||
| Q1 24 | $0.07 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.2M | $90.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $231.0M | $341.7M |
| Total Assets | $339.7M | $461.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $90.9M | ||
| Q3 25 | — | $93.3M | ||
| Q2 25 | — | $75.5M | ||
| Q1 25 | — | $95.3M | ||
| Q4 24 | — | $98.7M | ||
| Q3 24 | $7.2M | $162.3M | ||
| Q2 24 | $15.4M | $177.9M | ||
| Q1 24 | $1.8M | $168.8M |
| Q4 25 | — | $341.7M | ||
| Q3 25 | — | $378.6M | ||
| Q2 25 | — | $377.6M | ||
| Q1 25 | — | $379.6M | ||
| Q4 24 | — | $395.7M | ||
| Q3 24 | $231.0M | $385.5M | ||
| Q2 24 | $231.1M | $389.1M | ||
| Q1 24 | $220.3M | $392.6M |
| Q4 25 | — | $461.5M | ||
| Q3 25 | — | $494.9M | ||
| Q2 25 | — | $493.3M | ||
| Q1 25 | — | $482.6M | ||
| Q4 24 | — | $499.5M | ||
| Q3 24 | $339.7M | $491.2M | ||
| Q2 24 | $338.5M | $483.7M | ||
| Q1 24 | $321.8M | $492.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.6M | $-771.0K |
| Free Cash FlowOCF − Capex | — | $-1.8M |
| FCF MarginFCF / Revenue | — | -2.9% |
| Capex IntensityCapex / Revenue | — | 1.6% |
| Cash ConversionOCF / Net Profit | 1.40× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-8.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-771.0K | ||
| Q3 25 | — | $-3.9M | ||
| Q2 25 | — | $108.0K | ||
| Q1 25 | — | $-125.0K | ||
| Q4 24 | — | $2.0M | ||
| Q3 24 | $4.6M | $13.2M | ||
| Q2 24 | $19.1M | $6.2M | ||
| Q1 24 | — | $4.0M |
| Q4 25 | — | $-1.8M | ||
| Q3 25 | — | $-4.6M | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | — | $-974.0K | ||
| Q4 24 | — | $1.1M | ||
| Q3 24 | — | $12.2M | ||
| Q2 24 | — | $5.2M | ||
| Q1 24 | — | $3.4M |
| Q4 25 | — | -2.9% | ||
| Q3 25 | — | -8.7% | ||
| Q2 25 | — | -3.2% | ||
| Q1 25 | — | -2.3% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 23.7% | ||
| Q2 24 | — | 11.0% | ||
| Q1 24 | — | 7.6% |
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 1.3% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 2.0% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 2.0% | ||
| Q2 24 | — | 2.3% | ||
| Q1 24 | — | 1.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.21× | ||
| Q3 24 | 1.40× | 14.05× | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CMCL
Segment breakdown not available.
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
